This year, AbbVie has continually been a big spender in the TV ad drug stakes, and it’s showing no signs of slowing down. After launching two new Rinvoq commercials this summer, the Big Pharma is now ...

Skyrizi is available in multiple forms, including single-dose prefilled pens and single-dose prefilled syringes. The typical dosages of Skyrizi may vary depending on which condition is being treated.

Skyrizi is a biologic medication used to treat several inflammatory conditions, including Crohn’s disease, plaque psoriasis, psoriatic arthritis, and ulcerative colitis, in adults. Dosage typically ...

One of the up-and-coming drugs AbbVie is pinning its hopes on to make up for falling Humira sales, Skyrizi, just beat out its competitor Stelara, from Johnson & Johnson on many points in a Phase 3 ...

Physicians have delivered a boost to AbbVie’s hopes of turning Skyrizi into a $17-billion-a-year drug. The 101 gastroenterologists polled by Spherix Global Insights talked up Skyrizi’s promise in ...

Skyrizi (risankizumab-rzaa) and Humira (adalimumab) are prescription drugs that treat conditions such as psoriatic arthritis. The cost of both drugs depends on several factors. Skyrizi and Humira are ...

Skyrizi is used to treat certain inflammatory conditions, such as plaque psoriasis. The drug starts working after your first dose. The Food and Drug Administration (FDA) has approved Skyrizi to treat ...